SEATTLE, July 05, 2021, (MEDGADGET) — Global Medical Imaging Devices Market – Competitive Analysis
Advancement in technology in medical imaging such as mobile imaging devices and 3-D ultrasonic holography, which do not use harmful radiation, has led to an improvement in the diagnosis and treatment methods. Pediatric patients are comparatively more radiosensitive than adults. Therefore, manufacturers are focusing on designing safer and effective X-ray imagining devices that have relatively low levels of harmful radiations, built specially for pediatric patients as encouraged by the U.S. FDA. Moreover, companies are developing software in order to improve diagnosis and treatment methods and provide quantitative analysis tools and advanced visualization. Technological advancements such as apps which can be linked with medical imaging devices are expected to provide manufacturers a competitive edge in the market. For instance, the University of Pittsburgh Medical Center (UPMC) is the development partner for GE Health Cloud. The new cloud system allows managing files produced by magnetic resonance imaging (MRIs), computed tomography (CT) scanners, ultrasound machines, and other imaging devices.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1125
The competitive analysis for companies operating in the medical imaging devices market includes top 10 players based on their 2016 revenue – Siemens AG, GE Healthcare, Philips Healthcare, Fujifilm Holdings Corporation, Hitachi Ltd, Shimadzu Corporation, Toshiba Medical Systems Corporation, Hologic, Inc., Samsung Medison, and Carestream Health.
Philips Healthcare
Company Description – Philips Healthcare is engaged in manufacturing and selling a wide range of products, which include healthcare IT solutions, diagnostic imaging systems, patient monitoring, and cardiac devices. Philips Healthcare operates as a subsidiary of Koninklijke Philips.
Key highlights – The company is focusing on increasing its share and profitability in the global medical imaging devices market by offering products in oncology and radiology segments which include smart devices, software, and services. Philips Healthcare is also focused on developing ultrasound products in general imaging and gynecology/obstetrics. In 2014, Philips Healthcare received U.S. FDA approval for spectral imaging system (IQon Spectral CT). The IQon Spectral CT is a leading, new, high standard for medical imaging. According to the Radiological Society of North America study in 2013, conducted on the Philips IQon Spectral CT and traditional imaging methods, the Philips IQon Spectral CT system exhibited enhanced diagnosis in up to 70% cases compared to traditional imaging methods. In August 2019, Koninklijke Philips N.V., acquired the Healthcare Information Systems (HCIS) business of Carestream Health Inc., and integrated it with Philips’ Enterprise Diagnostic Informatics business.
GE Healthcare
Company Description – GE Healthcare manufactures cardiac devices, patient monitoring devices, and medical imaging systems. GE Healthcare is a subsidiary of GE Electrical. The company offers a wide range of products and services which include patient monitoring and diagnostics, software and IT, drug discovery biopharmaceutical manufacturing technologies, and performance improvement solutions.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/1125
Key highlights – The healthcare systems such as diagnostic imaging and clinical systems accounted for 70% of GE Healthcare’s revenue in 2016. The U.S. and Europe accounted for 66% of the healthcare revenue. The company is focusing on building mobile- and cloud- based apps as a part of its product expansion strategy. For instance, in 2015, the GE Health Cloud and app was launched in the U.S. The new cloud system is expected to connect over 500,000 GE imaging machines which can help clinicians deliver better outcomes. In September 2015, GE Healthcare Canada and the Biomedical Translational Imaging Centre (BIOTIC) collaborated for the development of Halifax-based technology commercialization program in order to advance software technology in medical imaging.
Siemens AG
Company Description – Siemens Healthcare — a subsidiary of Siemens — is a medical technology and healthcare company that manufacturers clinical diagnostics and therapeutic systems. The company’s Healthineers segment operates through six different businesses, namely diagnostic imaging, laboratory diagnostics, advanced therapies, ultrasound, point-of-care diagnostics, and services.
Key highlights – The company is focusing on research and development activities to introduce advanced medical technologies for in vitro diagnosis. Healthineers profit is mainly driven by diagnostic imaging business which accounted for the largest share in the Healthineers overall profit. In September 2019, Siemens Healthineers invested US$ 2.7 Mn in the medical imaging manufacturing plant in India.
Carestream Health
Company Description: Carestream Health provides medical imaging and healthcare information technology solutions. The company’s product portfolio includes analog X-ray, radiography systems, ultrasound, cone beam CT, and healthcare IT solutions.
Key highlights – In 2016, Carestream Touch Prime Ultrasound Systems received Health Canada license. The system provides wireless connectivity and rapid transfer of images and data. It also enhances clinician’s access to critical imaging information. Furthermore, the new system is useful for imaging of overweight and obese patients as the system provides deep penetration of the abdomen. The company is developing 3D and 4D technologies to produce high resolution images that can improve diagnostics in radiology. In 2016, Carestream’s OnSight 3D Extremity System that uses cone beam CT (CBCT) technology received U.S. FDA 510(k) clearance. The system reduced the dose as compared to traditional CT systems. It also provided high-resolution 3D images.
Fujifilm Holdings Corporation
Company Description: – Fujifilm and its subsidiaries are engaged in manufacturing and selling a wide range of information solutions and medical imaging. Through its healthcare segment, the company offers medical imaging systems.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1125
Key highlights – The sales of the CALNEO series — a DR cassette digital X-ray imaging diagnostic system — and a digital mammography system contributed to the growth of the company’s healthcare segment. In January 2017, Fujifilm Medical Systems received pre-marketing U.S. FDA approval for the digital breast tomosynthesis (DBT) software. The DBT is an optional software that was upgraded to support the Aspire Cristalle digital mammography system. Radiologists using the Aspire Cristalle digital mammography system with DBT will be able to enhance clinical efficiency and provide diagnostic accuracy. In 2018, Fujifilm Medical Systems launched FCT Embrace, a wide bore computed tomography (CT) imaging unit having 64 or 128 slice configurations developed for application in oncology and radiology. In July 2019, FUJIFILM Medical Systems U.S.A. and FUJIFILM New Development U.S.A., inaugurated the new headquarters for medical devices in Lexington, Massachusetts.
Other Exclusive Reports:
Over-the-Counter Drugs Market – Global Competitive Analysis
Global Oncology Drugs Market – Competitive Analysis
Global Rare Disease Drugs Market – Competitive Analysis
Medical Devices Market – Global Competitive Analysis
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837